Table 3.
Reported healthy individuals with MASP-2 deficiency due to homozygosity for the p.D120G mutation
| Reported MASP2 p.D120G homozygous individuals | Year | Ref |
|---|---|---|
| 1. Adult British individual (from a study of 314 family-based trios with offspring affected with psoriasis) | 2005 | [19] |
| 2. Adult Spanish individual (from a control group of 868 healthy adults in a study of adult CAP patients, adult SLE patients, and children with RRI) | 2006 | [9] |
| 3. Adult Spanish individual (from a control group of 868 healthy adults in a study of adult CAP patients, adult SLE patients, and children with RRI) | 2006 | [9] |
| 4. Adult Spanish individual (from a control group of 805 healthy adults in a study of adult CAP patients and patients without relevant infectious diseases) | 2008 | [7] |
| 5. Adult Italian individual (from a control group of 162 healthy individuals for a study of adult patients with HC) | 2008 | [17] |
| 6. Adult Polish individual (from a study of 179 children with dental caries) | 2014 | [20] |
| 7. Adult Polish individual (from a control group of 276 healthy individuals for a study of TB patients) | 2015 | [13] |
| 8. Pre-term Polish newborn (from a control group of 273 healthy newborns for a study of children with sepsis and non-septic infected babies) | 2016 | [21] |
| 9. Pediatric Spanish individual (from a control group of children with no history of respiratory diseases) | (current study) | |
CAP community-acquired pneumonia, SLE systemic lupus erythematosus, RRI recurrent respiratory infection, HC hepatocellular carcinoma, TB tuberculosis